The Europe breast cancer screening market was valued at US$ 1,231.82 million in 2019 and is projected to reach US$ 1,586.46 million by 2027; it is expected to grow at CAGR of 4.3% from 2020 to 2027.
Breast cancer is formed in the lobules, duct, fatty tissue, or fibrous connective tissue in breasts. Thus, ductal, lobular, invasive ductal, and invasive lobular carcinomas are the common types of breast cancer. Breast cancer has no symptoms in early stages;however, a lump in the breast can be the first sign of the development of breast cancer.
Market Insghts
Growing Initiatives for Breast Cancer Management
Growing grants and initiatives is favoring the growth of the breast cancer screening market. Breast cancer screening plays a significant role in determining the suitable procedure and required pace of treatment.Early screening reduces mortality rates due tobreast cancers; therefore, market players, as well as government authorities, are implementing new diagnostics or screening facilities. . The European Commission Initiative on Breast Cancer (ECIBC)develops the European Breast Guidelines andevidence-based references to provide women and healthcare providers bright, objective, and individualistic guidance on breast cancer screening and diagnosis.Additionally, the government provides funds for developing technologies for cancer detection. For instance, in February 2017, German genetic testing firm CeGaT received US$531,615 (€500,000) from the German Federal Ministry of Education and Research to support the development of liquid biopsy technology for the analysis of circulating tumor DNA.
Test Type-Based Market Insights
Based on test type,the breast cancer screeningmarket is further segmented into imaging test, immunohistochemistry test, genetic test, and blood marker test. The imaging testsegment held the largest share of the market in 2019,and it is also anticipated to register the highest CAGR in the market during the forecast period.
End User-Based Market Insights
Based on end user, the breast cancer screeningmarketis segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR during the forecast period.
Strategic Insights
Product launches and approvalsarecommonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the breast cancer screeningmarketadopt the expansion, collaboration, and product launch strategies to enlarge customer base acrossthe world.These strategies allow the players to maintain their brand name globally. For instance, in May 2018, Siemens Healthineers and ScreenPoint Medical collaboratedtodesign breast imaging software basedon artificial intelligence. This joint partnership also includes Siemens Healthineers owning a strategic minority interest in ScreenPoint Medical.
By Test Type
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,231.82 Million |
| Market Size by 2027 | US$ 1,586.46 Million |
| CAGR (2020 - 2027) | 4.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Test Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Breast Cancer Screening Market is valued at US$ 1,231.82 Million in 2019, it is projected to reach US$ 1,586.46 Million by 2027.
As per our report Europe Breast Cancer Screening Market, the market size is valued at US$ 1,231.82 Million in 2019, projecting it to reach US$ 1,586.46 Million by 2027. This translates to a CAGR of approximately 4.3% during the forecast period.
The Europe Breast Cancer Screening Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Breast Cancer Screening Market report:
The Europe Breast Cancer Screening Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Breast Cancer Screening Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Breast Cancer Screening Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Breast Cancer Screening Market
